Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

44 results about "Testis specific" patented technology

Testis specific 10 is a protein that in humans is encoded by the TSGA10 gene .

Association of TSPYL polymorphisms with SIDDT syndrome

The identification of a novel mutation in the testis specific Y-like gene and association of the mutation with SIDDT syndrome are disclosed. Methods for diagnosing SIDDT syndrome are disclosed. Methods for identifying compounds for use in the diagnosis and treatment of disorders associated with mutation in the TSPYL gene are also disclosed. The invention therefore provides nucleic acid sequences, genes, polypeptides, antibodies, vectors containing the gene, host cells transformed with vectors containing the gene, animal models for the disease, methods for expressing the polypeptide, genetic screening methods and kits, diagnostic methods and kits.
Owner:THE CLINIC FOR SPECIAL CHILDREN

Biomarkers for human papilloma virus-associated cancer

ActiveUS20090136486A1Microbiological testing/measurementAntibody ingredientsSynaptonemal complex protein 2Antigen
Cervical cancer cells and HPV+ head and neck cancer cells express three testis-specific genes not normally expressed in somatic cells: testicular cell adhesion molecule 1 (TCAM1), synaptonemal complex protein 2 (SYCP2) and stromal antigen 3 (STAG3). Among the three markers, TCAM1 and SYCP2 are early detection markers. Various methods for identifying a human or non-human animal as a candidate for further examination for cervical cancer, preneoplastic lesion for cervical cancer, head and neck cancer, or preneoplastic lesion for head and neck cancer are disclosed. Methods of detecting said cancers and preneoplastic lesions, methods of screening for drugs for treating said cancers and preneoplastic lesions, methods for monitoring the effectiveness of a treatment for said cancers, and methods of treating said cancers are also disclosed. Further disclosed are kits that can be used to practice the above methods.
Owner:WISCONSIN ALUMNI RES FOUND

Degradation of PA200 and acetylation-mediated core histones through proteasome

The invention discloses an application of PA200 proteins in preparation of products. The products have at least one of the following functions from (1) to (4): (1) combining with acetylated proteins; (2) promoting the degradation of the acetylated proteins; (3) participating in repair of DNA (deoxyribonucleic acid) damages of somatic cells; and (4) participating in the formation of sperms. The invention has breakthroughs in four following aspects: (1) finding a mechanism of regulation and control of degradation of the histones, the sperm formation and the DNA repair by acetylation; (2) revealing the degradation of the histones medicated by acetylation rather than ubiquitination through PA200 / Blm10 proteasome; (3) finding novel testis-specific proteasome containing PA200 and alpha 4s, and revealing the core histones as a first type biological substrate for the proteasome; and (4) revealing that a histone deacetylase inhibitor can promote the degradation of the histones which are induced by DNA double-strand breaks and medicated by acetylation, enhance the sensitivity of cells to DNA damages and easily lead to the death of the cells.
Owner:BEIJING NORMAL UNIVERSITY

Objective biochemical method for assessment of sperm quality

A method of testing sperm quality including obtaining a sample of sperm to be tested; detecting and measuring the testis-specific HspA2 chaperone protein (or, the chaperone protein homologues to HspA2) in human and animal sperm; and determining a sperm quality parameter based upon the chaperone protein, wherein an increased amount of the chaperone protein species indicates a higher sperm quality. The chaperone protein is detected and measured either by binding one or more antibodies specific to the sperm chaperone protein to the sperm and measuring the antibody content or measuring ATP bound to the sperm chaperone protein. In the case of the latter method, the chaperone protein may be detected and measured by measuring ATP bound to the sperm chaperone protein, and such measuring is by chaperone protein-bound and CK-B generated ATP measurement, or by bioluminescence of the chaperone protein bound-ATP.
Owner:HUSZAR GABOR B

Infertility control of genetically modified fish

A method of inducing male and / or female infertility in a genetically modified (GM) fish is disclosed. Also disclosed is a method of generating an infertile GM fish with a phenotype and / or genotype of interest. The method involves generation of a GM fish whose genome comprises a foreign transgene operably linked to a fish gonad-specific promoter selected from the group consisting of an ovary-specific promoter and a testis-specific promoter. The transgene comprises a suicide gene selected from the group consisting of a reductase and a photosensitizer, in which the reductase is operably linked to a reporter gene. Infertility of the GM fish is induced if the GM fish expressing the reductase is treated with an effective amount of a reductase-activated cytotoxic prodrug or if the GM fish expressing the photosensitizer is treated with light irradiation.
Owner:ACAD SINIC +1

Preparation and use of testes specificity protein 50 human source antibody

The present invention provides a preparation method of testicular specific protein 50 humanized single-chain antibody. Said invention utilizes phage antibody presentation technique and adopts the following steps: using human testicular specific protein 50 as target antigen, utilizing immunoaffinity screening process to screen the recombinant phage human antibody variable region gene library, separating and cloning TSP 50 specific single-chain antibody gene AI,AII and C8, then respectively inserting single-chain antibody gene AI, AII and C8 into prokaryotic expression vector PelB, transforming Rosetta microphyte, utilizing IPTG to induce and express exogenous protein, after the thallus is cracked, ulitizing Ni-NTA column affinity chromatography to obtain purified single-chain antibody, utilizing ELISA method to judge that it can be specifically combined with TSP 50 holoprotein and 50 peptide, and using gene engineering measure to massively express said hamonized single-chain antibody. Said invention also discloses application of the testicular specific protein 50 humanized single-chain antibody for diagnosing and curing the diseases of female mammary carcinoma, etc. related to TSP 50.
Owner:李玉新 +2

Biomarkers For Human Papilloma Virus-Associated Cancers

ActiveUS20110301059A1Microbiological testing/measurementLibrary screeningSynaptonemal complex protein 2Cancer cell
Cervical cancer cells and HPV+ head and neck cancer cells express three testis-specific genes not normally expressed in somatic cells: testicular cell adhesion molecule 1 (TCAM1), synaptonemal complex protein 2 (SYCP2) and stromal antigen 3 (STAG3). Among the three markers, TCAM1 and SYCP2 are early detection markers. Various methods for identifying a human or non-human animal as a candidate for further examination for cervical cancer, preneoplastic lesion for cervical cancer, head and neck cancer, or preneoplastic lesion for head and neck cancer are disclosed. Methods of detecting said cancers and preneoplastic lesions, methods of screening for drugs for treating said cancers and preneoplastic lesions, methods for monitoring the effectiveness of a treatment for said cancers, and methods of treating said cancers are also disclosed. Further disclosed are kits that can be used to practice the above methods.
Owner:WISCONSIN ALUMNI RES FOUND

Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods

The invention provides novel STAMP2 nucleic acid molecules, polypeptides, antibodies, and modulatory compounds for use in methods of diagnosing, treating, and preventing diseases and conditions of the prostate and testis, such as cancer.
Owner:PRESIDENT & FELLOWS OF HARVARD COLLEGE

Method for enhancing chemical sensitivity or radiosensitivity of cancer cells by inhibiting expression of tspyl5

Disclosed herein is a method for enhancing sensitivity of cancer cells to compounds or radiation by inhibiting the expression of testis-specific protein, Y-encoded like 5 (TSPYL5). More specifically, because methylation of TSPYL5 protein expressed in lung cancer cell line was inhibited to increase the expression level of the gene, resistance to stress such as radiation or anticancer agents was increased. Because the sensitivity of cancer cells to stress such as radiation or anticancer agents was increased by inhibiting the expression of the TSPYL5 gene to promote the apoptosis of the cells, an anticancer supplement agent containing an inhibitor of the expression or activity of the TSPYL5 gene of the present invention inhibits the growth of cancer cells and enhances the sensitivity to various stresses to maximize the apoptosis. Thus, when used in combination with radiotherapy or chemotherapy, the anticancer supplement agent may be used very usefully for anticancer treatment.
Owner:KOREA ATOMIC ENERGY RES INST

Biological control of insects

Provided herein are modified insects having decreased expression of a testis-specific coding region compared to a control insect. In one embodiment, the modified insect includes the characteristic of reduced fertility, reduced fecundity, or a combination thereof, when compared to the control insect. Optionally and preferably, the competiveness of the modified insect is not significantly reduced compared to the control insect. Also included herein are methods for making a modified insect, and methods for using the modified insects, including making populations of modified insects and use of the modified insects in sterile insect technique for biological control.
Owner:UNIVERSITY OF MANITOBA

Prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods

The invention provides novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, antibodies, and modulatory compounds for use in methods of diagnosing, treating, and preventing diseases and conditions of the prostate and testis, such as cancer.
Owner:PRESIDENT & FELLOWS OF HARVARD COLLEGE

Prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods

The invention provides novel STAMP2 nucleic acid molecules, polypeptides, antibodies, and modulatory compounds for use in methods of diagnosing, treating, and preventing diseases and conditions of the prostate and testis, such as cancer.
Owner:PRESIDENT & FELLOWS OF HARVARD COLLEGE

Human testicle specificity protein 50 gene expression regulator screening system and method of screening its gene expression regulator

The present invention relates to a screening model of human testicular specific protein 50 (TSP50) expression regulator and method for screening TSP 50 gene expression regulator. Said screening system contains a recombinant carrier containing exogenous polynucleotide and host cell transformed or transfected by said recombinant carrier. Said recombinant carrier contains original carrier and human TSP 50 gene promoter, in which the described original carrier contains a report gene and contains no promoter, the described human TSP 50 gene promoter is connected to upstream of report gene, and the activity of human TSP 50 gene promoter has correlation with expression of report gene. Said invention also discloses a method for constructing said screening system and its application.
Owner:NORTHEAST NORMAL UNIVERSITY

Method for regulating cancer stem cell growth by inhibiting phosphorylation of 120th threonine residue of TSPYL5 protein, a composition containing the peptide sequence functioning to inhibit the phosphorylation and a use thereof

The present invention relates to a peptide suppressing the phosphorylation of threonine (T120), the 120th residue of TSPYL5 (testis-specific Y-like protein 5), which is specifically as follows. The present inventors constructed T120D, the mutant of the 120th residue threonine (T120) of TSPYL5, and T120A-TSPYL5 gene and then transfected cells with them in order to investigate the effect of phosphorylation on T120 residue. As a result, wild-type TSPYL5 and T120D moved into nucleus and stayed there. But in the case of T120A-TSPYL5, TSPYL5 did not move into nucleus and instead it was expressed only in cytoplasm. The protein could not bind to AKT, either. Instead, ubiquitination of TSPYL5 was increased but SUMOylation was inhibited. Also, the expressions of ALDH1-A1, -A3, CD44 gene and protein were reduced, and thereby the growth and metastasis of lung cancer cells were suppressed and sphere formation was reduced. Based on the observation above, the inventors constructed the peptide composed of the amino acid sequences represented by SEQ. ID. NO: 43 or NO: 44 that could inhibit phosphorylation of the 120th residue threonine of TSPYL5. The said peptide can be effectively used as a composition for the inhibition of cancer cell growth, metastasis, and cancer stem cell growth.
Owner:KOREA ATOMIC ENERGY RES INST

A method for regulating cancer stem cell growth by inhibiting phosphorylation of 120th threonine residue of tspyl5 protein, a composition containing the peptide sequence functioning to inhibit the phosphorylation and a use thereof

The present invention relates to a peptide suppressing the phosphorylation of threonine(T120), the 120th residue of TSPYL5 (testis-specific Y-like protein 5), which is specifically as follows. The present inventors constructed T120D, the mutant of the 120th residue threonine(T120) of TSPYL5, and T120A-TSPYL5 gene and then transfected cells with them in order to investigate the effect of phosphorylation on T120 residue. As a result, wild-type TSPYL5 and T120D moved into nucleus and stayed there. But in the case of T120A-TSPYL5, TSPYL5 did not move into nucleus and instead it was expressed only in cytoplasm. The protein could not bind to AKT, either. Instead, ubiquitination of TSPYL5 was increased but SUMOylation was inhibited. Also, the expressions of ALDH1-A1, -A3, CD44 gene and protein were reduced, and thereby the growth and metastasis of lung cancer cells were suppressed and sphere formation was reduced. Based on the observation above, the inventors constructed the peptide composed of the amino acid sequences represented by SEQ. ID. NO: 43 or NO: 44 that could inhibit phosphorylation of the 120th residue threonine of TSPYL5. The said peptide can be effectively used as a composition for the inhibition of cancer cell growth, metastasis, and cancer stem cell growth.
Owner:KOREA ATOMIC ENERGY RES INST

Gene expressed in prostate cancer

A novel testis-specific gene expressed in human prostate cancer, designated 22P4F11, is described. Analysis of 22P4F11 mRNA expression in normal prostate, prostate tumor xenografts, and a variety of normal tissues indicates that the expression of this gene is testis specific in normal tissues. The 22P4F11 gene is also expressed in human prostate tumors, in some cases at high levels. A full length cDNA encoding 22P4F11 is provided. The 22P4F11 transcript and / or protein may represent a useful diagnostic marker and / or therapeutic target for prostate cancer.
Owner:AGENSYS

Human testis specific serine/threonine kinase 1 and 2

The present invention relates to a family of testis specific kinases (the tssk family), nucleic acid sequences encoding those kinases and antibodies against the kinases. The invention is further directed to the use of those kinases as targets for isolating specific inhibitors or antagonists of tssk kinase activity. Such inhibitors are anticipated to have use as contraceptive agents.
Owner:UNIV OF VIRGINIA ALUMNI PATENTS FOUND

Human epididymis expression sperm binding protein HEL-90, encoding gene and application thereof

The invention belongs to the field of biotechnology and medicine, and discloses a new human epididymis specific expression sperm binding protein HEL-90 as well as preparation and application thereof. The invention discloses an amino acid sequence of the HEL-90 protein and provides a recombination expression carrier carrying the DNA sequence for encoding the protein. The protein is located in the middle rear and tail parts of a mature sperm. A RT-PCR result shows that the gene is mainly and specifically expressed in the epididymis and testis and is negative in the heart, liver, spleen, kidney and stomach. A band of about 24 KD is detected in the corpus epididymidis part with Western blot. The HEL-90 protein can be used as a target protein for researching and developing immunity contraceptive as well as clinical diagnosis and treatment for male sterility. A method for detecting a corresponding gene or protein based on development of the HEL-90 protein can be widely used for the research field of reproductive medicine.
Owner:李建远

Idiosyncratic antigen protein, and antigen peptide of liver cancer orchis pellet

InactiveCN100348614CFor the purpose of treating cancerEnhanced transcriptional regulationPeptide/protein ingredientsFermentationT cellTumor antigen
This invention relates to hepatic cancer-testis specific anti-genetic protein and anti-genetic peptide. The anti-genetic protein has the amino acid sequence shown in SEQ ID No. 1 (from AA 108-AA 191). The anti-genetic protein and anti-genetic peptide can be used as E2F activity-blocking agent in PRB / E2F signal transduction, and have antagonistic effects on homologous analogue TEDP-1. The tumor antigen protein can decompose in cells to obtain peptide fragments, which can bind with the main histocompatibility complex (MHC)-I molecules, and be recognized by T cells. The anti-genetic protein and anti-genetic peptide can be applied in anti-tumor drugs.
Owner:PEKING UNIV

Preparation and use of testes specificity protein 50 human source antibody

The present invention provides a preparation method of testicular specific protein 50 humanized single-chain antibody. Said invention utilizes phage antibody presentation technique and adopts the following steps: using human testicular specific protein 50 as target antigen, utilizing immunoaffinity screening process to screen the recombinant phage human antibody variable region gene library, separating and cloning TSP 50 specific single-chain antibody gene AI,AII and C8, then respectively inserting single-chain antibody gene AI, AII and C8 into prokaryotic expression vector PelB, transforming Rosetta microphyte, utilizing IPTG to induce and express exogenous protein, after the thallus is cracked, ulitizing Ni-NTA column affinity chromatography to obtain purified single-chain antibody, utilizing ELISA method to judge that it can be specifically combined with TSP 50 holoprotein and 50 peptide, and using gene engineering measure to massively express said hamonized single-chain antibody. Said invention also discloses application of the testicular specific protein 50 humanized single-chain antibody for diagnosing and curing the diseases of female mammary carcinoma, etc. related to TSP 50.
Owner:李玉新 +2
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products